Sechenov School
Home › Pharmacology › Prokinetics

Prokinetics

For medical students2 min readUpdated 2026-10-10

Prokinetics are medications that stimulate the propulsive motility of the gastrointestinal tract. They are widely used in gastroenterology to manage functional motility disorders of often unclear etiology, including gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS).

Mechanism of D2 blockersD2 receptor blockade removes the inhibitory effect of dopamine on acetylcholine release.
Side effectsMetoclopramide crosses the blood-brain barrier and can cause extrapyramidal symptoms.
Serotoninergic risksCisapride and tegaserod carry a significant arrhythmogenic risk.

Classification of Motility Stimulants

Drugs that enhance gastrointestinal motor activity are divided into several main groups based on their receptor targets:

  1. Direct-acting cholinomimetics (bethanechol) and anticholinesterases (neostigmine methylsulfate). These are referred to as cholinergic agents. They are rarely used in current clinical practice because they increase overall smooth muscle tone without providing the coordinated propulsive activity required for normal digestion.
  2. Dopamine D2 receptor antagonists. This group includes classic prokinetics such as metoclopramide and domperidone.
  3. Serotonin 5-HT4 receptor agonists (serotonergic agents). Examples include tegaserod and cisapride.

Dopamine D2 Receptor Antagonists

Physiologically, dopamine inhibits acetylcholine release in enteric nervous system ganglia. Prokinetics in this group block D2 receptors, thereby removing this inhibition. The resulting increase in acetylcholine release stimulates gastric and intestinal propulsive activity.

Metoclopramide has a complex mechanism of action. In addition to its primary antidopaminergic effect (D2 receptor blockade), it stimulates 5-HT4 receptors and blocks 5-HT3 receptors. It predominantly affects the upper gastrointestinal tract.

Domperidone also blocks D2 receptors, accounting for its prokinetic activity. However, its crucial pharmacokinetic feature is that it does not cross the BBB to a clinically significant extent. Consequently, unlike metoclopramide, domperidone lacks central nervous system side effects.

Serotonergic Prokinetics

This group of drugs targets serotonin receptors to stimulate motility. However, their clinical use is severely limited due to cardiovascular side effects.

Tegaserod is a partial 5-HT4 receptor agonist. Its mechanism involves activating intrinsic primary afferent neurons, stimulating acetylcholine release, and enhancing gut motility throughout the gastrointestinal tract—from the esophagus and stomach to the small intestine and ascending colon. Its main indication was irritable bowel syndrome, but its use is strictly limited due to prominent arrhythmogenic effects.

Cisapride stimulates 5-HT4 receptors while simultaneously blocking 5-HT3 receptors. Historically, it was widely used to treat gastroparesis and reflux disease. Currently, its use is severely restricted due to a high risk of cardiac complications, including ventricular fibrillation and torsades de pointes.

Mnemonic

To remember the difference between D2 blockers, use the mnemonic: "Metoclopramide Metches the Mind (crosses the BBB), while Domperidone stays Down (acts peripherally and does not cross the BBB)."

Frequently asked questions

What side effects are characteristic of metoclopramide?

Metoclopramide is associated with central nervous system, endocrine, and gastrointestinal side effects:

  • Neurological — extrapyramidal symptoms resulting from the drug crossing the blood-brain barrier and blocking dopamine in the CNS.
  • Endocrine — galactorrhea, hyperprolactinemia, amenorrhea, and gynecomastia (caused by systemic dopamine blockade).
  • Gastrointestinal — diarrhea and flatulence.
What are the absolute contraindications to metoclopramide?

Contraindications for metoclopramide include:

  • Gastrointestinal hemorrhage.
  • GI perforation.
  • Mechanical bowel obstruction.
  • Concomitant use of neuroleptics (risk of extrapyramidal disorders).
  • Breastfeeding.
What is the mechanism of the prokinetic action of macrolides (e.g., erythromycin)?

Macrolides such as erythromycin act as motilin receptor agonists, directly stimulating GI motility and accelerating gastric emptying. Because of this rapid prokinetic effect, erythromycin is used off-label for acute upper GI preparation before endoscopy (e.g., clearing blood clots during gastrointestinal bleeding).

What is the mechanism of action of itopride?

Itopride acts via a dual mechanism:

  • Dopamine D2 receptor antagonism.
  • Acetylcholinesterase inhibition.

Consequently, itopride enhances acetylcholine release and prevents its degradation. In GERD, it normalizes upper GI motility and reduces transient lower esophageal sphincter relaxations. Combined with proton pump inhibitors, it significantly increases lower esophageal sphincter pressure, enhances gastric motility, accelerates gastric emptying, and restores gastroduodenal coordination.

Why are cholinergic agents rarely used as prokinetics?

Direct cholinomimetics and anticholinesterases increase GI smooth muscle tone, but they fail to provide adequate coordinated propulsive activity.

What is the main difference between domperidone and metoclopramide?

Both block D2 receptors, but domperidone does not cross the blood-brain barrier, thereby avoiding central side effects such as extrapyramidal symptoms.

Why has cisapride been largely withdrawn from clinical use?

Due to a high risk of dangerous cardiac arrhythmias, including ventricular fibrillation and torsades de pointes.

Go deeper

More topics in Pharmacology

Antiparkinsonian DrugsIntramuscular and Subcutaneous InjectionsDemulcentsAtropinePropranolol: Pharmacology, Mechanism and Clinical UseEpilepsy: Pathogenesis and Seizure TypesMechanisms of Action of AntibioticsVirusesHIV Integrase InhibitorsEmetine and AminoquinolColony-Stimulating FactorsMultivitamins and CytaminsPharmacology →